Murali Ramachandran (CIK 1870016) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-11-26). Recent activity: Buy KAPA (152,672 shares), Buy KAPA (14,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-26 | Kairos Pharma, LTD. (KAPA) | VP of Research and Development | Buy | 152,672 | $0 |
| 2025-02-24 | Kairos Pharma, LTD. (KAPA) | VP of Research and Development | Buy | 14,000 | $0 |
Source: SEC Form 4 filings · as of 2025-11-26